[New tuberculostatics under experiment. Results and prospects].
Anastasatu
C
C
D000617:Aminoglycosides / Q000627:therapeutic use; D000818:Animals; D000995:Antitubercular Agents / Q000037:antagonists & inhibitors / Q000627:therapeutic use*; D004353:Drug Evaluation, Preclinical; D004352:Drug Resistance, Microbial; D066298:In Vitro Techniques; D008826:Microbial Sensitivity Tests; D009169:Mycobacterium tuberculosis / Q000187:drug effects; D015363:Quinolones / Q000627:therapeutic use; D012293:Rifampin / Q000031:analogs & derivatives / Q000627:therapeutic use; D014376:Tuberculosis / Q000188:drug therapy
D000617:Aminoglycosides; D000995:Antitubercular Agents; D015363:Quinolones; D012293:Rifampin
Tuberculostatice noi în curs de experimentare. Rezultate şi perspective.